(MPO) – 2019’s passing marks two years without the type of annual blockbuster deal the medical device industry had become accustomed to. That’s not to say M&A activity was quiet—a number of the world’s largest medtech makers spent billions last year to boost their portfolios. […]
(Evaluate) – Thanks to Thermo Fisher Scientific and Invitae, two groups brave enough to push ahead with multibillion-dollar acquisitions during a pandemic, the total value of medical device M&A announced in the first half of 2020 nudged over $15bn. […]
(MassDevice) – Twenty-six more medical and surgical societies and healthcare associations have endorsed guidelines for the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic. […]
Conformis today said its full-time employees that were furloughed in March will return to active employment as early as April 27. The employees’s return is due to a $4.7 million loan made available to the company under the Paycheck Protection Program offered by the U.S. SBA. […]
(MD+DI) – Like many of its peers, including Boston Scientific and Johnson & Johnson, Medtronic’s business has been impacted by procedure deferrals as healthcare systems around the world have deferred most elective procedures to focus on COVID-19. […]
(MassDevice) – Shares of two of the largest orthopedic device companies started climbing this morning on news of a new White House recommendation that elective surgical procedures may resume. […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes